| 注册
首页|期刊导航|四川医学|一种新型富血小板因子血浆制剂的动物实验安全性研究

一种新型富血小板因子血浆制剂的动物实验安全性研究

张向飞 丁雪琴 陈静娴 赵俊 高雪华 海泉 赵令卉 盛琴 郑小奇 马波 王宁 雷占东

四川医学2016,Vol.37Issue(3):245-247,3.
四川医学2016,Vol.37Issue(3):245-247,3.DOI:10.16252/j.cnki.issn1004-0501-2016.03.003

一种新型富血小板因子血浆制剂的动物实验安全性研究

The Safety of a Novel Preparation Platelet Factor Rich Plasma in Animal

张向飞 1丁雪琴 2陈静娴 3赵俊 1高雪华 2海泉 1赵令卉 2盛琴 1郑小奇 2马波 1王宁 2雷占东1

作者信息

  • 1. 四川省再生医学工程技术研究中心,四川 成都610094
  • 2. 成都清科生物科技有限公司,四川 成都610094
  • 3. 四川大学华西医院再生医学研究中心,四川 成都610041
  • 折叠

摘要

Abstract

Objective Evaluation the safety of novel preparation Platelet Factor Rich Plasma( PFRP) in animal. Methods 30 C57 mice were randomly divided into three groups;Low Dose group(LD group),High Dose group(HD group)and Control group. PFRP were prepared according to related patent,different concentration PFRP was injected into caudal vein of LD and HD mice at a volume of 200μL every two weeks for three times respectively. Mice of Control group only received the same volume in-jection of Normal Saline. Body weight,mental activity and motor function of all three groups mice were recorded every week. Mice were sacrificed at day 42 to investigate the effect of PFRP on main organs( heart,liver,spleen,lung and kidney) by organ coefficient ration and HE staining. Results At day 14,the body weight of HD group was significantly higher than that of Control group,how-ever no obvious difference of body weight was found between different groups at any other day and no abnormal mental activity or movement was found in all three groups during the process. At day 42,organ coefficient ration of heart in HD group was significant-ly higher than that in Control group,and no other obvious difference of main organ coefficient ration was found in HD group and in LD group compared to Control group. Furthermore,HE staining revealed that there was no difference in all main organs among the three groups. Conclusion Caudal vein injection of PFRP prepared according to our patent in LD group didn’t cause abnormal e-vents on mice.

关键词

富血小板因子血浆/临床前/安全性

Key words

PFRP/pre-clinical/safety

分类

医药卫生

引用本文复制引用

张向飞,丁雪琴,陈静娴,赵俊,高雪华,海泉,赵令卉,盛琴,郑小奇,马波,王宁,雷占东..一种新型富血小板因子血浆制剂的动物实验安全性研究[J].四川医学,2016,37(3):245-247,3.

基金项目

2015年四川省科技支撑计划基金资助课题(编号:2015SZ0020) (编号:2015SZ0020)

四川医学

OACSTPCD

1004-0501

访问量0
|
下载量0
段落导航相关论文